Ottoline Dunmore
FDA’s generative AI strategy faces four key questions
Generative AI regulation takes center stage as the FDA unveils its strategy, tackling approval pathways, safety standards, industry uncertainty, and oversight.
New Treatment Improves Survival in First-Line Small Cell Lung Cancer
New treatment improves survival in first-line small cell lung cancer with a combination of tarlatamab and durvalumab, showing a significant clinical benefit.
Hospitals struggle with high costs of CAR T-cell therapy programs
Hospitals face steep CAR T-cell therapy costs, from drug pricing to staffing and safety protocols, straining smaller clinics and outpatient programs.
Myasthenia Gravis Patients Live Longer Than Multiple Sclerosis
Myasthenia Gravis survival is better than Multiple Sclerosis in new data. Patients with MG live 15 to 19 years longer than MS…
New Study Examines Weight Loss Outcomes
New study reveals significant weight loss outcomes with up to 16.6% mean weight loss and reduced liver fat through effective treatment.
CAR T Cell Therapy Gets New Guidelines
CAR T cell therapy gets new guidelines to protect patients and ensure safe delivery, reflecting advancements in the field of cancer treatment.
Rural Patients Face Gaps in Hospice Access and Care
Rural patients face gaps in hospice access and care intensity compared to urban settings. Learn how Medicare hospice disparities affect rural decedents…
Global Study Assesses Leukemia Care Needs
Global study reveals significant challenges in managing leukemia therapies and care capabilities across different countries and clinical settings.
Health Gains Slowing Under Trump Policies
Health gains are slowing under Trump policies, affecting communities like Dewey City with poor living conditions and health concerns.
Can Video Games Improve Focus and Concentration?
More Than Just Entertainment For years, video games were often criticized for being little more than a distraction. Today, the conversation is…